IMUX
Immunic, Inc.Company with tickers: IMUX
Market Cap
$205.28M
Shares Outstanding
13,621,526
CIK
1280776
CUSIP
4525EP101
13F Activity (30d)
3 filings
2 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Erik Lundgren | Chief Executive Officer | Appointed | 2026-05-27 |
| Michael W. Bonney | Chair of the Board | Appointed | 2026-05-19 |